The mouse embryo ~3.5 d after fertilization forms a blastocyst comprising three lineages 1 : the extraembryonic trophectoderm (TE), the PrE and the pluripotent Epi ( . Notably, each of these stem cell lines is a useful model of the blastocyst cell lineage that they represent. Mouse ES and TS cells have been used successfully for many years to model Epi or TE biology, including the mechanisms of pluripotency maintenance and placental development, respectively. Recently derived XEN cell lines have the distinctive characteristic of cells with at least two morphologies: they are highly refractile as well as epitheliallike 3 (Fig. 2) , and they are only beginning to be used to understand the mechanisms of PrE development with significance for stem cell and developmental biology.
or immunosurgery, to isolate and to plate the inner cell mass 28, 29 . In 2005, Kunath et al. 3 reported the first isolation and characterization of XEN cells using methods based on existing protocols of deriving ES 28 and TS cells 2, 30, 31 . In this case, embryonic day 3.5 blastocysts were cultured on mouse embryonic fibroblast (MEF) cells until they formed an outgrowth that, as in routinely used ES and TS cell derivation protocols, was subsequently disaggregated to promote the proliferation of the different cell types present in the blastocyst. In both procedures, XEN cell outgrowths could be observed alongside ES or TS cells, respectively, suggesting that these conditions are also permissive for XEN cell derivation.
Our experience has been that slight modifications to these protocols (especially media conditions and time of disaggregation) can favor the propagation of XEN cells over that of ES or TS cells. We have also found that, in our hands, TS cell conditions are generally less efficient for the derivation of XEN cell lines compared with ES cell conditions (21% and 56% efficiency, respectively). ES cells start appearing from the outgrowths first and are less resilient, which might facilitate the ability of XEN cells to outcompete them in a culture dish. TS cells, in contrast, reach their proliferative peak around the same time as XEN cells and tend to outcompete XEN cells present in the same cultures, especially in the presence of recombinant FGF4 (ref. 2) or FGF2 (bFGF), the latter of which can elicit the same effect 31 and is slightly more cost effective.
XEN cell establishment by transcription factor overexpression
In classical experiments, Davis et al. 32 demonstrated that the expression of a single transcription factor, MyoD, was sufficient to convert fibroblasts into myogenic cells. More recently, transcription factor-mediated cell-fate switches have been demonstrated for several other cell types, including the reprogramming of fibroblasts into induced pluripotent stem cells via ectopic expression of the POU domain, class 5, transcription factor 1 (Pou5f1, also known as Oct4), Klf4, Sox2 and Myc (also known as c-Myc) 33 .
Ectopic transcription factor expression has also been shown to induce the conversion of XEN cells from ES cells (reviewed in ref. 6 ). Niwa and colleagues 8, 34 demonstrated that the expression of Gata4 or Gata6 alone is sufficient to induce the conversion of ES cells into XEN cells. Notably, these GATA-derived XEN cells share the molecular and functional characteristics of embryo-derived XEN cells, including contribution to PrE lineages in chimeric embryos 34 . XEN-like cells have also been generated by ectopic expression of Sox17 (refs. 14, [35] [36] [37] . It is unclear whether Sox17 alone is sufficient to drive XEN cell commitment, as these cells retain the expression of ES cell-associated genes, such as Nanog and Oct4 (refs. 14,35,38) , and their contribution to chimeras has not yet been reported. Moreover, it is unclear whether alternative PrE-associated transcription factors can be used to convert ES to XEN cells.
The simplest method used to derive XEN cells from ES cells is the expression of Gata6 either by transfection of a circular plasmid or a linearized DNA using chemical or nonchemical (e.g., electroporation) methods. There are several chemical-based transfection approaches. The most widely used methods for ES cells are lipidbased lipopolyamines 39 and cationic polymer-based transfection (reviewed in ref. 40) . Lipopolyamines (e.g., lipofection) work by coating a Gata6-cDNA plasmid with a cationic lipid, allowing the DNA to cross the negatively charged phospholipid ES cell membrane by endocytosis 41, 42 . Cationic polymers (e.g., Xfect) act by binding DNA and condensing it, thereby facilitating DNA entry into the cell cytoplasm 40, 43 . An advantage of lipopolyamines and cationic polymers is that they do not require specialized equipment, although the reagents may be cytotoxic and the ratio of DNA to transfection reagent needs to be optimized to the specific cell type 42 (reviewed in ref. 44) .
Electroporation is the principal alternative to chemical-based transfection approaches and is routinely used for ES cell transfection [45] [46] [47] . Electroporation allows for permeabilization of the ES cell membrane and transfection of a Gata6 cDNA via the application of a transient electrical field. Depending on the purity of the DNA preparation, this can be a highly efficient method and is most commonly used for gene targeting of ES cells. The choice of whether the Gata6 cDNA plasmid is introduced as a circular plasmid or as a linearized DNA can affect transfection efficiency, as supercoiled or open-circular DNA is optimal for transient expression, whereas linearized DNA is more recombinogenic and best suited for stable transfection [48] [49] [50] .
Continued passage of transiently transfected cells will result in the dilution of the exogenous DNA and may restrict the time window for subsequent analysis. Therefore, although it is initially more time consuming, the generation of stable transfected ES cells that have integrated a linearized Gata6 cDNA into the genome can be experimentally more consistent compared with transient transfection. By including a drug-resistance gene in the Gata6 cDNA-targeting plasmid, drug selection can be used to expand only targeted ES cells that retain the ability to overexpress the Gata6 cDNA. Another important consideration is the use of an efficient and robust promoter to drive exogenous Gata6 expression. In mouse ES cells, the cytomegalovirus (CMV) promoter may be silenced 51 . In contrast, the ubiquitin C (UBC) promoter, elongation factor 1α (EF1A) promoter, and the chicken β-actin (ACTB) promoter coupled with the CMV early enhancer (CAGG) have been reported to be more robustly expressed 51 . Although these are not described here, alternative approaches for Gata6 overexpression include viral transduction. Owing to potential toxicity, viral production and transduction require at least a category II tissue culture facility, and the silencing of retroviral transcription in XEN cells may obviate this approach 27 . Moreover, reversible overexpression of Gata6 can be engineered using an inducible expression system containing a tetracycline-responsive element (controlled by tetracycline or doxycycline), a mutant estrogen-responsive element (controlled by 4-hydroxytamoxifen) or a glucocorticoid-responsive element (controlled by dexamethasone). When combined with drug selection, an inducible system is an effective means of overexpressing Gata6 simultaneously in all cells. Although overexpression of Gata6 may initially be a simpler method to drive XEN differentiation, a major note of caution is that its ubiquitous expression may hinder the ability of converted XEN cells to differentiate into subtypes of XEN cells. One major limitation may be that constitutive Gata6 expression blocks differentiation of induced XEN cells into visceral endoderm subtypes, as in vivo these cells lack Gata6 expression while retaining the expression of Gata4 (refs. 52,53) . Here we describe a method to constitutively express Gata6 in mouse ES cells, which can be modified to overexpress other genes such as Gata4 or to introduce an inducible expression system as has been described previously 34, 54, 55 . Moreover, transposon systems such as piggyBac 56 may also be used, although these methods have not yet been shown to convert ES to XEN cells.
XEN cell establishment by growth factor conversion of ES cells
Although ES cells largely contribute to the Epi in chimera embryos, it has been observed that committed XEN and TS cells also arise within pluripotent culture conditions 14, 57, 58 . The presence of TSand XEN-like cells within ES cell cultures suggests that ES cells may have a broader cell fate potential and are therefore able to differentiate into stable extraembryonic stem cell lines directly. Indeed, ES cell aggregation results in the formation of embryoid bodies with an outer layer of XEN cells 12 , and growth factors such as retinoic acid have been shown to differentiate embryonic carcinoma and ES cells into XEN-like cells [9] [10] [11] 59 . Moreover, the culture of ES cells in serumfree medium on fibronectin-coated dishes at high density has been suggested to promote visceral endoderm differentiation 60 . However, it was unclear whether self-renewing XEN cells could be differentiated directly from mouse ES cells without gene manipulation. We have recently expanded on these studies by developing a technique to convert ES cells directly into stable XEN (cXEN) cell lines that are equivalent to embryo-derived XEN cells 13 . We previously demonstrated that cXEN cells are molecularly indistinguishable from embryo-derived XEN and iXEN (i.e., transcription factor induced) cells and are equivalently responsive to differentiation-promoting factors (i.e., bone morphogenetic protein (BMP)-induced visceral endoderm differentiation). Our efforts to generate chimera embryos from cXEN cells resulted in contribution to the parietal endoderm at early postimplantation stages (K.K.N., M. Kang and A.-K.H., unpublished observations), as has been reported for XEN cells derived from embryos 3 . Here we describe our method for converting mouse ES cells into stable cXEN cell lines using growth factors. Specifically, we use retinoic acid together with activin, which has been demonstrated to promote primitive endoderm development in vivo and in vitro 17, 61 . Notably, although retinoic acid and activin have been shown to differentiate ES cells into neurons and definitive endoderm, respectively, we find that the combination of both factors promotes XEN cell differentiation. We previously tested a range of retinoic acid concentrations from 0 to 100 µM and a range of activin concentrations from 0 to 20 ng ml − 1 . Although XEN-like cells can emerge in the absence of exogenous retinoic acid and activin 14 , the proportion of XEN-like cells is enhanced (40.3%) in 0.01 µM retinoic acid and 10 ng ml − 1 activin 13 . We therefore use the lowest dose of retinoic acid and activin that gives us the highest efficacy of XEN cell emergence, although it is presently unclear whether different concentrations of these growth factors influence the identity of the XEN cells obtained. Thus far, we have been able to derive XEN cell lines from any mouse ES cell line and mouse strain unless the cells are mutant for a gene required for XEN establishment and/or maintenance 13 , although the speed of conversion can vary with any given cell line. An important consideration is the initial heterogeneity that emerges after growth factor treatment. As with the protocol for XEN cell derivation from embryos, selecting cells with XEN cell morphology facilitates the expansion of stable cXEN cells that are able to self-renew indefinitely. This ES cell conversion protocol is particularly useful for determining the genetic requirement for XEN cell function using mutant mouse ES cells without the necessity for mutant mice. 28 ). A simple mouth pipettor can be made by inserting the pointed end of a P1000 filter tip into one end of a cut rubber tube and attaching a plastic mouthpiece to the other. A pulled glass Pasteur pipette can now be attached to the filter tip. Pasteur pipettes can be pulled either over a flame or by using a micropipette puller (Fig. 3) . 5 MEFs per well for a six-well plate or 7.8 × 10 5 cells per 100-mm tissue culture plate, and then incubate the plates overnight at 37 °C. The number of plates to prepare depends on the number of XEN cell derivations to be performed. Generally, four plates (4-well plates) per pregnant mouse for Steps 6A and 6B are sufficient, or a six-well plate for Steps 6C-F. ? trouBlesHootInG
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The morning before starting the derivation, aspirate the medium on the MEF feeders and replace it with ES cell medium for derivation using ES cell conditions (Step 6A), with TS cell medium for derivation using TS cell conditions (Step 6B) or with XEN cell medium for derivation from ES cells (Steps 6C-F). When required, plate MEFs that carry drug-resistance genes, such as DR4 MEFs (resistant to neomycin, hygromycin, puromycin and Zeocin) (table 1) (Fig. 4) .  crItIcal step The plates should be incubated in a 5% CO 2 humidified incubator at 37 °C, except while performing
Step 6A(i-iv), which can be performed under ambient conditions. ? trouBlesHootInG (ii) Day 2. Observe the plates under a microscope. The blastocysts should have hatched from the zona pellucida and attached to the feeder layer (Fig. 4) . (iii) Day 3. Observe the plates under a microscope. The blastocysts should have started to form an outgrowth (Fig. 4) (Fig. 4) . (vii) Day 15-indefinite. When 70% confluency is achieved, passage the cells onto a feeder-covered well of a six-well plate.
From this point onward, the cells can be cultured in standard XEN medium. Repeat the step, but passage the cells onto a feeder-covered 100-mm dish. Passage the cells two more times. If desired, remove feeders and freeze the XEN cell line as described in Step 7. (B) Xen cell derivation under ts cell conditions (i) Day 1. Thoroughly clean a dissection microscope with 70% (vol/vol) ethanol. By using a mouth-controlled pipette, place one blastocyst per feeder-covered well in the prepared four-well plates (Fig. 4) .  crItIcal step The plates should be incubated in a 5% CO 2 humidified incubator at 37 °C, except while performing (
Step 6B(i-iv)), which can be performed under ambient conditions. ? trouBlesHootInG (ii) Day 2. Observe the plates under a microscope. The blastocysts should have hatched from the zona pellucida and attached to the MEF feeder layer (Fig. 4) . (iii) Day 3. Observe the plates under a microscope. The blastocysts should have started to form an outgrowth (Fig. 4) .
Carefully aspirate the medium and replace it with fresh TS cell medium. (Fig. 4) . Exchange the medium with 10 ml of standard ES cell medium and incubate the plate overnight in a 5% CO 2 humidified incubator at 37 °C. (ix) Days 3-9. If the Gata6-cDNA plasmid has been engineered to also express a drug-resistance gene, then drug selection can be used to expand successfully transfected cells. Exchange the medium with 10 ml of standard XEN cell medium 5 ). Incubate the plate overnight at 37 °C in standard XEN medium. The cell density is an important determinant of differentiation efficiency, and as different ES cell lines proliferate at different rates, we recommend determining the optimal density for each line. (v) Day 2. Twenty-four hours after the initial plating, aspirate the standard XEN medium and replace it with 2 ml of cXEN derivation medium per well (Fig. 5) . Incubate the plate overnight in a 5% CO 2 humidified incubator at 37 °C. other day depending on confluency. XEN-like cells with stellate and refractile morphology will emerge ~5 d after the first passage on MEFs; however, the well will also contain cells of different morphologies. Use standard XEN medium hereafter. During the first (and sometimes second) passage, the cXEN cells recover better when MEFs are present, although they are not a requirement. FGF2/FGF4 and heparin can also be added during the derivation, but they too are not a requirement as long as endogenous Fgf4 is intact. 
antIcIpated results
We have used the protocols described here to establish XEN cell lines from either mouse blastocysts or ES cells. XEN cell lines exhibit characteristic heterogeneous morphology with both highly refractile phase-bright and epithelial-like cells (Figs. 2,  4 and 5). XEN cells can be distinguished from mouse ES cells as the latter form dome-shaped clusters of cells with characteristic high nuclear-to-cytoplasmic ratio 4, 5 , whereas the former grow as individual cells and the nucleus of each cell is not clearly distinguishable (compare Fig. 2 ). XEN cells are also distinct from TS cells that grow as epithelial colonies comprising cells with distinct nuclei and can differentiate into multinucleated trophoblast giant cells in vitro 2 (compare Fig. 2) . It was previously demonstrated that XEN cells oscillate between these two morphologies 3 . All XEN cell lines retain the expression of key XEN-associated genes including the GATA transcription factor Gata4, the SOX factor Sox7 and Disabled homolog 2 Dab2 (supplementary Fig. 1) . Notably, these genes are not homogeneously expressed in all cells within a XEN cell line (supplementary Fig. 1) , and it remains unclear whether heterogeneity in morphology and gene expression reflects a fixed or oscillating heterogeneity representing distinct XEN cell types or substrates present in culture. Notably, mouse XEN cells usually lack the expression of ES cell-associated genes including octamer-binding transcription factor Oct4 (supplementary Fig. 1 ) and Nanog. XEN cells self-renew indefinitely in culture in the absence of exogenous growth factors such as FGF2 (refs. 13,16) . Moreover, XEN cells can be directed to differentiate into α-fetoprotein (Afp)-expressing visceral endoderm-like cells with the addition of BMP4 (refs. 18,19) and are committed to primitive endoderm-derived lineages in chimeric embryos 3, 34 . Although not reported in the literature, in our own experience the karyotype of XEN cells can change over time and cell lines can acquire karyotypic anomalies with extended passage in culture (N.S. and A.-K.H., unpublished observations). It is therefore preferable to work with cells that are of as low a passage as possible. It should be noted that even clonal XEN cell lines exhibit some degree of variability, for example, in the ratio of cells exhibiting different morphologies and/or in the expression of molecular markers. It is currently not clear whether this inherent variability reflects the cell of origin within an embryo or ES cell culture, cell culture history or an unidentified stochastic or deterministic factor. Furthermore, although there is no 'gold standard' XEN cell line that is used across laboratories, as a point of reference, CMV promoter may be silenced in ES cells We recommend using a plasmid with an EF1A or CAGG promoter to ensure robust expression 6D Low transfection efficiency Serum in the medium may interfere with DNA-liposome complex formation
Opti-MEM I can be used during the overnight incubation instead of ES cell medium without penicillin or streptomycin to improve the transfection efficiency; however, this may compromise ES cell viability especially when first establishing methods for XEN cell culture within a laboratory, it is advisable to obtain an established and characterized XEN cell line from another laboratory. In contrast to ES cells, no clear strain biases have been reported for the derivation of XEN cells from embryos or conversion from ES cells. This is likely because the protocols for XEN cell derivation, as provided here, are very efficient as compared with most non-inhibitor protocols for ES cell derivation. Notably, even though XEN cells are a relatively new stem cell type, which can be used in a number of applications, in the future, it will be important to compare the differentiation efficiency and molecular identity of XEN cells derived under distinct culture conditions to determine whether there may be biases in potential and/or differences in gene expression. In all, XEN cells are emerging as a useful stem cell model for understanding the convergence of signaling and transcriptional control during XEN cell-fate specification and differentiation.
